The Hague Local Division of the Unified Patent Court (UPC) delivered its decision in Advanced Cell Diagnostics (ACD) v Molecular Instruments (MI) on 18 November 2025.
ACD had asserted that MI’s HCR™ RNA-ISH technology infringed European Patents EP1910572 and EP2500439. The Court decided that there was no infringement of the asserted patents, either literally or by equivalence.
MI was represented in the UPC by the combined team of Gowling WLG (UK) LLP, Boult Wade Tennant LLP, and De Brauw Blackstone Westbroek N.V.
For further details see the press release here.